Araştırma Makalesi

Relationship of restless legs syndrome with blood parameters

Cilt: 47 Sayı: 2 30 Haziran 2022
PDF İndir
EN TR

Relationship of restless legs syndrome with blood parameters

Abstract

Purpose: We aimed to investigate the factors affecting the etiopathogenesis by comparing the restless legs syndrome patients with the healthy control group in terms of some laboratory parameters. Materials and Methods: Patients who were diagnosed with restless legs syndrome were included in the study. A control group that was similar in terms of age and gender was formed. Both groups were compared in terms of iron, ferritin, iron-binding capacity, folate, vitamin B12, vitamin D, calcium, magnesium, ALT, AST, hemogram, creatinine, fasting blood sugar, and thyroid hormone levels. Results: 37 patients with restless legs syndrome and 41 controls were included in the study. In the restless legs syndrome group hemoglobin, ferritin, iron, fasting blood sugar, vitamin D, and fT4 values were 12.7 (10.3-16.0) g/dL, 37.3 (3.7-89.4) mg/L, 62 (21-195) μg/dL, 96 (65-250) mg/L, 11.26 (4.20-41.57) ug/L and 1.24 (0.73-2.14) µg/dL respectively, they were 14.8 (12.3-16.1) g/dL, 56 (9-189) mg/L, 90 (30-245) µg/dL, 91 (70-107) mg/L, 17.31 (5.73-32.90) µg/L and 1.08 (0.63-2.04) µg/dL respectively in the control group.There were statistically significant differences between the groups in terms of hemoglobin, ferritin, iron, fasting blood sugar, vitamin D, and fT4 levels. Conclusion: Hemoglobin and iron parameters, vitamin D levels, fasting blood sugar and T4 levels should be evaluated in patients with restless legs syndrome and should be replaced if necessary. Correction of deficiencies may be beneficial for patients' clinics.

Keywords

Restless Legs Syndrome , Iron Parameters , vitamin D

Kaynakça

  1. 1. Klingelhoefer L, Bhattacharya K, Reichmann H. Restless legs syndrome. Clinical Medicine. 2016;16(4):379.
  2. 2. Zintzaras E, Kitsios GD, Papathanasiou AA, et al. Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis. Clinical therapeutics. 2010;32(2):221-237.
  3. 3. Sayin S, Atilla FD. Demir Eksikliğinin Gözden Kaçan Klinik Prezantasyonu; Huzursuz Bacak Sendromu. Ankara Medical Journal. 2019;19(3):694-697.
  4. 4. Üçgün AB, Kilit TP, Onbaşı K. DİYABETİK HASTALARDA HUZURSUZ BACAK SENDROMU SIKLIĞI VE İLİŞKİLİ FAKTÖRLERİN ARAŞTIRILMASI. PREVALENCE. 2019;30:38.
  5. 5. Ohayon MM, O’Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep medicine reviews. 2012;16(4):283-295.
  6. 6. Taşdemir M, Erdoğan H, Börü ÜT, Dilaver E, Kumaş A. Epidemiology of restless legs syndrome in Turkish adults on the western Black Sea coast of Turkey: A door-to-door study in a rural area. Sleep medicine. 2010;11(1):82-86.
  7. 7. Sayin S, Atilla F. Overlooked clinical presentation of iron deficiency; Restless Leg Syndrome. Ankara Med J. 2019:19-13.
  8. 8. Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Movement disorders: official journal of the Movement Disorder Society. 2001;16(6):1159-1163.
  9. 9. Benediktsdottir B, Janson C, Lindberg E, et al. Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep medicine. 2010;11(10):1043-1048.
  10. 10. Ekbom K-A. Restless legs syndrome. Neurology. 1960;10(9):868-868.

Kaynak Göster

MLA
Güntel, Murat, vd. “Relationship of restless legs syndrome with blood parameters”. Cukurova Medical Journal, c. 47, sy 2, Haziran 2022, ss. 776-82, doi:10.17826/cumj.1091685.